Sanofi is shelling out US$1bn for a license granting the French pharma company access to a potential multiple...
Up To Date
Latest News
Oslo-based microbiome expert Bio-Me A/S has raised NOK10m in a new funding round.
French biopharma company NFL Biosciences has raised €5m following its IPO at Euronext Growth Paris.
With a €20m financing round under its belt, Promethera Therapeutics is poised to start its Phase IIb study for...
Early-stage venture capital investor Novalis Biotech has closed its Biotech Acceleration Fund at €25m to drive...
Swedish Cellink AB has announced a bid of $110m to take over all shares of Discover Echo Inc., 11% of which to...
Share
